The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Abstract
Fibroblast growth factor 21 (FGF21) is a metabolic regulator that provides efficient and durable glycemic and lipid control in various animal models. However, its potential to treat obesity, a major health concern affecting over 30% of the population, has not been fully explored. Here we report that systemic administration of FGF21 for 2 wk in diet-induced obese and ob/ob mice lowered their mean body weight by 20% predominantly via a reduction in adiposity. Although no decrease in total caloric intake or effect on physical activity was observed, FGF21-treated animals exhibited increased energy expenditure, fat utilization, and lipid excretion, reduced hepatosteatosis, and ameliorated glycemia. Transcriptional and blood cytokine profiling studies revealed effects consistent with the ability of FGF21 to ameliorate insulin and leptin resistance, enhance fat oxidation and suppress de novo lipogenesis in liver as well as to activate futile cycling in adipose. Overall, these data suggest that FGF21 exhibits the therapeutic characteristics necessary for an effective treatment of obesity and fatty liver disease and provides novel insights into the metabolic determinants of these activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“prolonged administration of FGF21 or FGF21 analogues has important metabolic effects, including a marked decrease in body weight in rodents and non-human primates, and more modest effects on body weight in humans3,40,58,77,78.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [77]
In the citing paper
“Pharmacological administration of FGF21 to obese rodents reverses diabetes and obesity through increasing energy expenditure77,78.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [77]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“A myriad of studies ensued demonstrating that administering FGF21 to obese or diabetic rodents and primates markedly reduced body weight and significantly improved carbohydrate and lipid homeostasis (21, 64, 65, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“When administered to diabetic and obese animal models, FGF21 provides multiple metabolic benefits and has been shown to decrease blood glucose levels and body weight, improve insulin and leptin sensitivity, improve plasma lipid profiles, and decrease hepatic steatosis (21, 64, 141, 142).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“Importantly, in animal models FGF21 treatment not only prevents (64) but also reverses diabetes and obesity (21, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“Since FGF21 administration increases energy expenditure and the browning of adipose tissues in vivo (21, 64, 141), it was hypothesized that FGF21 regulates adaptive thermogenesis in response to cold.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“It is clear that FGF21 treatment elicits significant metabolic changes in many tissues, including the liver and adipose tissues (21, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“FGF21’s ability to reduce body weight, glucose levels, and lipid concentrations in models of obesity generated substantial initial interest”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [116]
Citations
Cites
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Self-citationCellular signaling by fibroblast growth factor receptors
Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,923
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123
Handschin, C., & Spiegelman, B. M. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0037 · Cited by 1,090
New drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,012
Self-citationIdentification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
Cohen, P., Miyazaki, M., Socci, N. D., Hagge-Greenberg, A., Liedtke, W., Soukas, A. A., Sharma, R., Hudgins, L. C., Ntambi, J. M., & Friedman, J. M. (2002) · Science · doi:10.1126/science.1071527 · Cited by 826
Cited by
Sorted by citations
Items 501–600 of 995
The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_16 · Cited by 42
Kim, J. K., Yoo, C., Cha, Y. H., & Kim, Y. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.014 · Cited by 33
Plasma FGF21 levels are increased in patients with hypothyroidism independently of lipid profile
Lee, Y., Park, Y. J., Ahn, H. Y., Lim, J., Park, K. U., Choi, S. H., Park, D. J., Oh, B., Jang, H. C., & Yi, K. H. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0427 · Cited by 33
Weng, Y., Ishino, T., Sievers, A., Talukdar, S., Chabot, J., Tam, A. S. P., Duan, W., Kerns, K. M., Sousa, E. A., He, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22456-w · Cited by 33
Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21
Sawicki, K. T., Chang, H., Shapiro, J. S., Bayeva, M., Jesus, A. D., Finck, B. N., Wertheim, J. A., Blackshear, P. J., & Ardehali, H. (2018) · JCI Insight · doi:10.1172/jci.insight.95948 · Cited by 33
Beige Fat, Adaptive Thermogenesis, and Its Regulation by Exercise and Thyroid Hormone
Phillips, K. J. (2019) · Biology · doi:10.3390/biology8030057 · Cited by 35
Zhang, Y., Cao, X., Chen, L., Qin, Y., Xu, Y., Tian, Y., & Chen, L. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12848 · Cited by 31
Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Agrawal, S., Maity, S., Alraawi, Z., Al-Ameer, M., & Kumar, T. K. S. (2020) · Current Drug Targets · doi:10.2174/1389450121999201012201926 · Cited by 34
En, M., Kazantseva, A. Y., Dubinina, A., Jakovleva, T., Balybina, N., Baranov, K. O., & Бажан, Н. М. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910561 · Cited by 33
Shah, N. Z., Abdalla, M. A., Deshmukh, H., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211042145 · Cited by 39
Archer, A., Venteclef, N., Mode, A., Pedrelli, M., Gabbi, C., Clément, K., Parini, P., Gustafsson, J.-Α., & Korach-André, M. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1151 · Cited by 33
Molecular mechanisms of fatty liver in obesity
Gan, L., Xiang, W., Xie, B., & Yu, L. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0410-2 · Cited by 37
Yadav, P., Khurana, A., Bhatti, J. S., Weiskirchen, R., & Navik, U. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106426 · Cited by 32
Wang, Y.-S., Ye, J., Cao, Y.-H., Zhang, R., Liu, Y., Zhang, S.-W., Dai, W., & Zhang, Q. (2019) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2018-136002 · Cited by 32
Lindegaard, B., Hvid, T., Grøndahl, T. S., Frøsig, C., Gerstoft, J., Højman, P., & Pedersen, B. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055632 · Cited by 32
Wang, C., Dai, J., Yang, M., Deng, G., Xu, S., Jia, Y., Boden, G. H., Ma, Z. A., Yang, G., & Li, L. (2014) · FEBS Journal · doi:10.1111/febs.12767 · Cited by 32
Yılmaz, Ü., Tekin, S., Demir, M. T., Çiğremiş, Y., & Sandal, S. (2018) · The Journal of Physiological Sciences · doi:10.1007/s12576-018-0595-7 · Cited by 30
A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling
Shi, S. Y., Lu, Y., Richardson, J., Min, X., Weiszmann, J., Richards, W. G., Wang, Z., Zhang, Z., Zhang, J., & Li, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-29396-5 · Cited by 31
Girer, N. G., Carter, D., Bhattarai, N., Mustafa, M. G., Denner, L. A., Porter, C. C., & Elferink, C. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040950 · Cited by 31
Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges
Tian, H., Zhang, S., Liu, Y., Wu, Y., & Zhang, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054583 · Cited by 33
Liu, Y., Wang, C., Wang, Y., Ma, Z., Xiao, J., McClain, C. J., Li, X., & Feng, W. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.08.003 · Cited by 32
Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases
Cheung, B. M. Y., & Deng, H. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.904745 · Cited by 32
Schlegel, G., Ringseis, R., Keller, J., Schwarz, F. J., Windisch, W. M., & Eder, K. (2012) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2012.01323.x · Cited by 32
FGF21 controls hepatic lipid metabolism via sex-dependent interorgan crosstalk
CHAFFIN, A. T. B., Larson, K. R., Huang, K.-P., Wu, C.-T., Nadejda, G., Fang, Y., Jayakrishnan, D., Sauza, K. A. S., Sims, L. C., Mohajerani, N., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.155848 · Cited by 31
Sun, M. Y., Yoo, E., Green, B. J., Altamentova, S. M., Kilkenny, D. M., & Rocheleau, J. V. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.10.028 · Cited by 31
The Ablation of Mitochondrial Protein Phosphatase Pgam5 Confers Resistance Against Metabolic Stress
Sekine, S., Akari, Y., Hattori, K., Sugawara, S., Naguro, I., Koike, M., Uchiyama, Y., Takeda, K., & Ichijo, H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.031 · Cited by 31
Cheng, S. T. W., Li, S. Y. T., & Leung, P. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102517 · Cited by 31
Ji, F., Liu, Y., Hao, J., Wang, L., Dai, M.-J., Shen, G.-F., & Yan, X. (2019) · Aging · doi:10.18632/aging.102293 · Cited by 31
Higashiura, Y., Furuhashi, M., Tanaka, M., Takahashi, S., Koyama, M., Ohnishi, H., Numata, K., Hisasue, T., Hanawa, N., Moniwa, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92292-y · Cited by 31
Fibroblast growth factor 21 as a potential master regulator in metabolic disorders
Velingkar, A., Vuree, S., Prabhakar, P. K., Kalashikam, R. R., Banerjee, A., & Kondeti, S. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00244.2022 · Cited by 32
Fibroblast growth factor 21 enhances cholesterol efflux in THP-1 macrophage-derived foam cells
Shang, W., Yu, X., Wang, H., CHEN, T., Fang, Y., Yang, X., Zhou, P., Nie, F., ZHOU, Q., & Zhou, J.-Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2731 · Cited by 32
Brown and beige fat: the metabolic function, induction, and therapeutic potential
Qian, S., Huang, H., & Tang, Q. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0382-2 · Cited by 33
Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations
Sánchez‐Infantes, D., Gallego-Escuredo, J. M., Díaz, M., Aragonès, G., Sebastiani, G., López‐Bermejo, A., de Zegher, F., Domingo, P., Villarroya, F., & Ibáñez, L. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.2 · Cited by 30
FGF21 as a Therapeutic Reagent
Zhao, Y., Dunbar, J. D., & Kharitonenkov, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_14 · Cited by 30
Self-citationThe role of FGF21 in type 1 diabetes and its complications
Zhang, J., Weng, W., Wang, K., Lu, X., Cai, L., & Sun, J. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25026 · Cited by 30
Hirai, T., Mitani, Y., Kurumisawa, K., Nomura, K., Wang, W., Nakashima, K., & Inoue, M. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.017 · Cited by 31
Arjmand, B., Tayanloo-Beik, A., Heravani, N. F., Alaei, S., Payab, M., Alavi-Moghadam, S., Goodarzi, P., Gholami, M., & Larijani, B. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00396 · Cited by 30
Roh, E., Hwang, S. Y., Yoo, H. J., Baik, S. H., Cho, B., Park, Y. S., Kim, H. J., Lee, S., Kim, B., Jang, H. C., et al. (2021) · Age and Ageing · doi:10.1093/ageing/afab178 · Cited by 31
Yang, M., Dong, J., Liu, H., Li, L., & Yang, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026359 · Cited by 30
Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes.
Matuszek, B., Lenart-Lipińska, M., Duma, D., Solski, J., & Nowakowski, A. M. (2010) · PubMed · Cited by 30
Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation.
Zhang, Q., Yan, L., Liang, T., Lu, X., Liu, X., Zhang, C., Jiang, X. M., Martin, R. C. G., Cheng, M., & Cai, L. (2015) · Europe PMC (PubMed Central) · Cited by 29
The mitochondrial integrated stress response: A novel approach to anti-aging and pro-longevity
Wang, X., & Zhang, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102603 · Cited by 29
Stone, K. P., Ghosh, S., Kovalik, J. P., Orgeron, M., Wanders, D., Sims, L. C., & Gettys, T. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-83380-0 · Cited by 29
Montgomery, M. K., Bayliss, J. A., Nie, S., Nardo, W. D., Keenan, S. N., Miotto, P. M., Karimkhanloo, H., Huang, C., Schittenhelm, R. B., Don, A. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28889-2 · Cited by 33
Murphy, M., Samms, R. J., Warner, A., Bolborea, M., Barrett, P., Fowler, M. J., Brameld, J. M., Tsintzas, K., Kharitonenkov, A., Adams, A. C., et al. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02383.x · Cited by 29
Self-citationα-Lipoic acid as a triglyceride-lowering nutraceutical
Pashaj, A., Xia, M., & Moreau, R. F. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0480 · Cited by 30
Thyroid hormone receptor regulates most genes independently of fibroblast growth factor 21 in liver
Zhang, A., Sieglaff, D. H., York, J. P., Suh, J. H., Ayers, S. D., Winnier, G. E., Kharitonenkov, A., Pin, C. L., Zhang, P., Webb, P., et al. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0440 · Cited by 29
Self-citationYe, X., Qi, J., Yu, D., Wu, Y., Zhu, S., Li, S., Wu, Q., Ren, G., & Li, D. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.008 · Cited by 29
Arias‐Calderón, M., Casas, M., Balanta‐Melo, J., Morales, C., Hernández, N., Llanos, P., Jaimovich, E., & Buvinic, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1059020 · Cited by 29
Friedline, R. H., Noh, H. L., Suk, S., Albusharif, M., Dağdeviren, S., Saengnipanthkul, S., Kim, B. K., Kim, A. M., Kim, L. H., TAUER, L. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49633-y · Cited by 31
Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations
Fletcher, J. A., Linden, M. A., Sheldon, R. D., Meers, G. M.-E., Morris, E. M., Butterfield, A. M., Perfield, J. W., Thyfault, J. P., & Rector, R. S. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00355.2015 · Cited by 28
Conjugated linoleic acid induces hepatic expression of fibroblast growth factor 21 through PPAR-α
Yu, J., Yu, B., Jiang, H., & Chen, D. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003205 · Cited by 28
Jurynec, M. J., & Grunwald, D. J. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.000703 · Cited by 26
Adapting to the cold: A role for endogenous fibroblast growth factor 21 in thermoregulation?
Klein Hazebroek, M., & Keipert, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00389 · Cited by 27
Reversal of obesity-induced hypertriglyceridemia by (R)-α-lipoic acid in ZDF (fa/fa) rats
Yi, X., Pashaj, A., Xia, M., & Moreau, R. F. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.063 · Cited by 27
Unger, R. H., Scherer, P. E., & Holland, W. L. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-10-0774 · Cited by 28
FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency
Dollet, L., Levrel, C., Coşkun, T., Lay, S. L., May, C. L., Ayer, A., Venara, Q., Adams, A. C., Gimeno, R. E., Magré, J., et al. (2016) · Diabetes · doi:10.2337/db16-0327 · Cited by 27
Forney, L. A., Stone, K. P., Wanders, D., & Gettys, T. W. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.12.002 · Cited by 28
Hirai, T., Nomura, K., Ikai, R., Nakashima, K., & Inoue, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.154 · Cited by 28
Socha‐Banasiak, A., Michalak, A., Pacześ, K., Gaj, Z., Fendler, W. M., Socha, A., Głowacka, E., Kapka, K., Gołąbek, V., & Czkwianianc, E. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-02199-2 · Cited by 27
Hepatic Phospholipid Remodeling Modulates Insulin Sensitivity and Systemic Metabolism
Tian, Y., Mehta, K., Jellinek, M. J., Sun, H., Lu, W., Shi, R., Ingram, K., Friedline, R. H., Kim, J. K., Kemper, J. K., et al. (2023) · Advanced Science · doi:10.1002/advs.202300416 · Cited by 26
Molecular Characterization and Mapping of Fgf21 Gene in a Foodfish Species Asian Seabass
Wang, L., Xia, J., Liu, X., Liu, P., Wan, Z. Y., & Yue, G. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090172 · Cited by 27
Tan, B. K., Sivakumar, K., Bari, M. F., Vatish, M., & Randeva, H. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065254 · Cited by 27
Fibroblast Growth Factor 21: A Novel Metabolic Regulator
Seo, J. A., & Kim, N. H. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.1.26 · Cited by 27
London, A., Richter, M. M., Sjøberg, K. A., Albrechtsen, N. J. W., Považan, M., Drici, L., Schaufuss, A., Madsen, L., Øyen, J., Madsbad, S., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.06.006 · Cited by 26
Liu, W., Huang, S., Shi, K., Zhao, C., Chen, L.-L., Braddock, M., Chen, Y., Feng, W., & Zheng, M. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.944898 · Cited by 26
Self-citationContribution of adaptive thermogenesis to the hypothalamic regulation of energy balance
Lage, R., Fernø, J., Nogueiras, R., Diéguez, C., & López, M. (2016) · Biochemical Journal · doi:10.1042/bcj20160012 · Cited by 28
Yu, D., Ye, X., Che, R., Wu, Q., Qi, J., Song, L., Guo, X., Zhang, S., Wu, H., Ren, G., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.059 · Cited by 26
Relationship of Selected Adipokines with Markers of Vascular Damage in Patients with Type 2 Diabetes
Spurná, J., Karásek, D., Kučerová, V., Goldmannová, D., Krystyník, O., Schovánek, J., & Zadražil, J. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0179 · Cited by 26
Maresin 1 Regulates Hepatic FGF21 in Diet‐Induced Obese Mice and in Cultured Hepatocytes
Martínez‐Fernández, L., González‐Muniesa, P., Sáinź, N., Laiglesia, L. M., Escoté, X., Martínez, J. A., & Moreno-Aliaga, M. J. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900358 · Cited by 26
FGF21 Mimics a Fasting-Induced Metabolic State and Increases Appetite in Zebrafish
Blanco, A. M., Bertucci, J. I., & Unniappan, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-63726-w · Cited by 26
Moderate-Intensity Continuous Training Improves FGF21 and KLB Expression in Obese Mice
Xiong, Y., Chen, Y., Liu, Y., & Zhang, B. (2020) · Biochemistry (Moscow) · doi:10.1134/s000629792008009x · Cited by 26
Self-citationExercise-Induced Fibroblast Growth Factor-21: A Systematic Review and Meta-Analysis
Kim, H., Jung, J., Park, S., Joo, Y., Lee, S., Sim, J., Choi, J., Lee, H., Hwang, G., & Lee, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087284 · Cited by 36
Molecular pathways regulating the formation of brown‐like adipocytes in white adipose tissue
Fu, J., Li, Z., Zhang, H., Mao, Y., Wang, A., Wang, X., Zou, Z., & Zhang, X. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2600 · Cited by 29
Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth
Megía, A., Gil-Lluís, P., Näf, S., Ceperuelo‐Mallafré, V., González-Clemente, J. M., Llauradó, G., Núñez‐Roa, C., Roche, K., Ballesteros, M., Yañez, R. E., et al. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0705-9 · Cited by 26
Lamp-2 deficiency prevents high-fat diet-induced obese diabetes via enhancing energy expenditure
Yasuda‒Yamahara, M., Kume, S., Yamahara, K., Nakazawa, J., Chin‒Kanasaki, M., Araki, H., Araki, S., Koya, D., Haneda, M., Ugi, S., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.010 · Cited by 26
Jeon, J. Y., Choi, S., Ha, E. S., Kim, T. H., Jung, J. G., Han, S. J., Kim, H. J., Kim, D. J., KANG, Y. Y., & Lee, K. W. (2016) · Endocrine · doi:10.1007/s12020-015-0845-x · Cited by 26
A role for nuclear receptors in mammalian hibernation
Nelson, C. J., Otis, J. P., & Carey, H. V. (2009) · Journal of Physiology · doi:10.1113/jphysiol.2008.167692 · Cited by 27
The depot-specific and essential roles of CBP/p300 in regulating adipose plasticity
Namwanje, M., Liu, L., Chan, M., Aaron, N., Kraakman, M. J., & Qiang, L. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0361 · Cited by 25
Fibroblast Growth Factor 21 Facilitates the Homeostatic Control of Feeding Behavior
Wu, C.-T., CHAFFIN, A. T. B., & Ryan, K. K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030580 · Cited by 24
Fibroblast Growth Factor‐21 and the Beneficial Effects of Long‐Chain n‐3 Polyunsaturated Fatty Acids
Villarroya, J., Flachs, P., Redondo‐Angulo, I., Giralt, M., Medříková, D., Villarroya, F., Kopecký, J., & Planavila, A. (2014) · Lipids · doi:10.1007/s11745-014-3948-x · Cited by 25
FGF21 suppresses hepatic glucose production through the activation of atypical protein kinase Cι/λ
Kong, L.-J., Feng, W., Wright, M., Chen, Y., Dallas-Yang, Q., Zhou, Y., & Berger, J. P. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.065 · Cited by 25
Self-citationTreatment of CIA Mice with FGF21 Down-regulates TH17-IL-17 Axis
Li, S., Yu, Y.-H., Li, L., Wang, W., & Li, D. (2015) · Inflammation · doi:10.1007/s10753-015-0251-9 · Cited by 25
Relationship between FGF21 and UCP1 levels under time-restricted feeding and high-fat diet
Chapnik, N., Genzer, Y., & Froy, O. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.017 · Cited by 25
Pennisi, G., Celsa, C., Spatola, F., Dallio, M., Federico, A., & Petta, S. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16224334 · Cited by 25
Larson, K. R., Jayakrishnan, D., Sauza, K. A. S., Goodson, M. L., CHAFFIN, A. T. B., Davidyan, A., Pathak, S. J., Fang, Y., Magaña, D. G., Miller, B. F., et al. (2024) · Endocrinology · doi:10.1210/endocr/bqae004 · Cited by 24
The cell adhesion molecule L1 regulates the expression of FGF21 and enhances neurite outgrowth
Huang, X., Hu, J., Li, Y., Yang, Z. Z., Zhu, H., Zhou, L., Ma, K., Schachner, M., Xiao, Z., & Li, Y. (2013) · Brain Research · doi:10.1016/j.brainres.2013.07.043 · Cited by 24
Chang, J. C., Durinck, S., Chen, M. Z., Martinez-Martín, N., Zhang, J. A., Lehoux, I. E., Li, H., Lin, M. H., Wu, J., Bainbridge, T. W., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45354-1 · Cited by 24
Development of a long acting FGF21 analogue-albumin fusion protein and its anti-diabetic effects
Watanabe, H., Miyahisa, M., Chikamatsu, M., Nishida, K., Minayoshi, Y., Takano, M., Ichimizu, S., Kobashigawa, Y., Morioka, H., Maeda, H., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.036 · Cited by 24
Nutritional Regulation of Hepatic FGF21 by Dietary Restriction of Methionine
Fang, H., Stone, K. P., Forney, L. A., Wanders, D., & Gettys, T. W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.773975 · Cited by 24
Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
Shimizu, M., & Sato, R. (2022) · Cells · doi:10.3390/cells11030505 · Cited by 25
Chen, J., Shi, J., Shao, H., Li, B., Ji, T., Staiculescu, D., He, J., Zhao, J., Cai, L., Liang, X. H., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2067-7 · Cited by 24
Intermittent fasting favorably modulates adipokines and potentially attenuates atherosclerosis
Zein, M. A., Zein, O., Diab, R., Dimachkie, L., Sahebkar, A., Al‐Asmakh, M., Kobeissy, F. H., & Eid, A. H. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115876 · Cited by 28
Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis
Guo, W., Cao, H., Shen, Y., Li, W., Wang, W. J., Cheng, L., Cai, M., & Xu, F. L. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00277-3 · Cited by 24
Elevated Serum Fibroblast Growth Factor 21 Levels in Patients With Hyperthyroidism
Xiao, F., Lin, M., Huang, P., Zeng, J., Zeng, X., Zhang, H., Li, X., Yang, S., Li, Z., & Li, X. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1797 · Cited by 24
Olszanecka‐Glinianowicz, M., Madej, P., Wdowczyk, M., Owczarek, A. J., & Chudek, J. T. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0539 · Cited by 25
Meissner, M., Herrema, H., van Dijk, T. H., Gerding, A., Havinga, R., Boer, T. S., Müller, M. M., Reijngoud, D., Groen, A. K., & Kuipers, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024564 · Cited by 24
Hao, L., Huang, N. K., Ito, K., Sae‐tan, S., Lambert, J. D., & Ross, A. C. (2016) · Journal of Nutrition · doi:10.3945/jn.115.216572 · Cited by 24
Claycombe, K., Vomhof‐DeKrey, E. E., Garcia, R. A. G., Johnson, W. T., Uthus, E. O., & Roemmich, J. N. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.01.008 · Cited by 24
Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice
Morrison, C. D., Zheng, H., Mumphrey, M. B., Townsend, R. L., Münzberg, H., Ye, J., & Berthoud, H. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.08.005 · Cited by 24
Metadata
- Authors
- Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A.
- Affiliations
- Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285
- Eli Lilly (United States) (US)
- Corresponding author
- Kharitonenkov, Alexei
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2008-08-07
- Volume
- 149
- Issue
- 12
- Pages
- 6018-6027
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2114650931
- Cited by
- 1,031
- References
- 26
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 58 · 2023: 63 · 2022: 57 · 2021: 72 · 2020: 67 · 2019: 76 · 2018: 72 · 2017: 64 · 2016: 78 · 2015: 85 · 2014: 71 · 2013: 62 · 2012: 61
- FWCI
- 12.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- FGF21, obesity, diet-induced obesity, ob/ob mice, energy expenditure, fat oxidation, de novo lipogenesis, hepatic steatosis, insulin resistance, leptin resistance, glycemia, lipid excretion, adipose tissue, metabolic therapy
- MeSH terms
- Animals, Body Weight, Energy Intake, Dietary Fats, Energy Metabolism, Fibroblast Growth Factors, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Motor Activity, Obesity, Leptin, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
